Author:
Martinez-Anton Asuncion,Gras Delphine,Bourdin Arnaud,Dubreuil Patrice,Chanez Pascal
Subject
Pharmacology (medical),Pharmacology
Reference541 articles.
1. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells;Abbaspour Babaei;Drug Design, Development and Therapy,2016
2. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis;Abdollahi;The Journal of Experimental Medicine,2005
3. SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer;Abrams;Molecular Cancer Therapeutics,2003
4. The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival;Ainsua-Enrich;The Journal of Immunology,2015
5. Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis;Akhmetshina;FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology,2008
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献